Feliz Navidea $29.79M Market Capitalization Navidea Biopharmaceuticals Inc. (NAVB.NYSE) announced today that it has received regulatory approval in India for its Lymphoaim, also referred to as Lymphoseek in the…
Latest News
Sparc AI (SPAI.C) completes development of drone advanced target acquisition system
Plurilock (PLUR.V) lands $19 million deal, largest in their history
Rex Resources (OWN.V) continues gearing up with BC gold property
Saga Metals (SAGA.V) investors get a mature resource explorer with a ‘weak hands’ discount
Ibero Mining (IMC.V): Deepening value in Portugal gold and copper projects
Troubadour Resources (TR.V): Hitting milestones and cashing up